Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ-PCR-Reference-Cited by-同舟云学术

Minimal residual disease monitoring in chronic lymphocytic leukaemia patients. A comparative analysis of flow cytometry and ASO IgH RQ-PCR

Published:2014-04-16 Issue:3 Volume:166 Page:360-368
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Raponi Sara¹,Della Starza Irene¹,De Propris Maria S.¹,Del Giudice Ilaria¹,Mauro Francesca R.¹,Marinelli Marilisa¹,Di Maio Valeria¹,Piciocchi Alfonso²,Foà Robin¹,Guarini Anna¹

Affiliation:

1. Haematology; Department of Cellular Biotechnologies and Haematology; Sapienza University; Rome Italy

2. GIMEMA Foundation; Rome Italy

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.12887/fullpdf

Reference25 articles.

1. Comparative analysis of minimal residual disease detection using four-color flow cytometry, consensus IgH-PCR, and quantitative IgH PCR in CLL after allogeneic and autologous stem cell transplantation;Böttcher;Leukemia,2004

2. Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis;Böttcher;Leukemia,2009

3. Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial;Böttcher;Journal of Clinical Oncology,2012

4. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis;Brochet;Nucleic Acids Research,2008

5. Acute lymphoblastic leukemia: monitoring minimal residual disease as a therapeutic principle;Brüggemann;Seminars in Oncology,2012

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitoring Response and Resistance to Treatment in Chronic Lymphocytic Leukemia;Cancers;2024-05-28

2. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2024;Journal of the National Comprehensive Cancer Network;2024-04

3. Performance of a novel eight‐color flow cytometry panel for measurable residual disease assessment of chronic lymphocytic leukemia;Cytometry Part B: Clinical Cytometry;2024-03-27

4. Chronic Lymphocytic Leukemia: Time-Limited Therapy in the First-Line Setting and Role of Minimal Residual Disease;Current Oncology Reports;2024-01-04

5. Importance of Minimal Residual Disease in the Era of Targeted Therapies in Chronic Lymphocytic Leukemia;Acta Haematologica;2023-10-30